Literature DB >> 25581393

Neuroticism scores increase with late-life cognitive decline.

Stephanie E Waggel1, Darren M Lipnicki2, Kim Delbaere3, Nicole A Kochan2,4, Brian Draper2,5,6, Gavin Andrews7, Perminder S Sachdev2,4,5, Henry Brodaty2,5,6.   

Abstract

OBJECTIVE: Neuroticism has been reported as both a risk factor for cognitive decline and a characteristic that increases in parallel with the development of mild cognitive impairment (MCI) and dementia. However, the evidence for these associations is inconclusive, and whether effects are stronger for particular cognitive domains is unknown. We investigated these issues and determined if associations differ among different components of neuroticism.
METHODS: A neuroticism scale (NEO-FFI) and neuropsychological test battery were administered to 603 older adults without dementia, with 493 of these reassessed two years later. Diagnoses of MCI and dementia (at follow-up) were made, and global cognition and performance in six cognitive domains quantified. The neuroticism components were negative affect, self-reproach, and proneness to psychological distress.
RESULTS: For the whole sample, neuroticism scores remained stable between baseline (15.3 ± 7.0) and follow-up (15.5 ± 7.0), as did all neuroticism component scores. However, there were declines in global cognition (p < 0.05) and particular cognitive domains (p < 0.001). Higher neuroticism was associated with poorer cognition cross-sectionally (p < 0.01), but did not predict cognitive decline. For 43 participants who developed incident MCI or dementia, there were increases in neuroticism (15.3 ± 6.4 to 17.1 ± 8.3, p < 0.05) and negative affect (p < 0.05). Declines in all cognitive measures except executive function were associated with increases in neuroticism and component scores (p < 0.05).
CONCLUSIONS: Late-life cognitive decline is associated with an increase in neuroticism scores. However, associations vary between different cognitive domains and components of neuroticism. An increase in neuroticism or negative affect scores may be a sign of MCI or dementia.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cognitive decline; late life; mild cognitive impairment; negative affect; neuroticism

Mesh:

Year:  2015        PMID: 25581393     DOI: 10.1002/gps.4251

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  6 in total

Review 1.  Personality Changes With Dementia From the Informant Perspective: New Data and Meta-Analysis.

Authors:  Maheen Islam; Mridul Mazumder; Derek Schwabe-Warf; Yannick Stephan; Angelina R Sutin; Antonio Terracciano
Journal:  J Am Med Dir Assoc       Date:  2019-01-07       Impact factor: 4.669

2.  Higher levels of neuroticism in older adults predict lower executive functioning across time: the mediating role of perceived stress.

Authors:  Chloé Da Silva Coelho; Emilie Joly-Burra; Andreas Ihle; Nicola Ballhausen; Maximilian Haas; Alexandra Hering; Morgane Künzi; Gianvito Laera; Greta Mikneviciute; Doriana Tinello; Matthias Kliegel; Sascha Zuber
Journal:  Eur J Ageing       Date:  2021-12-16

3.  Personality-cognition associations across the adult life span and potential moderators: Results from two cohorts.

Authors:  Sharon S Simon; Seonjoo Lee; Yaakov Stern
Journal:  J Pers       Date:  2020-04-04

4.  Personality Change in the Preclinical Phase of Alzheimer Disease.

Authors:  Antonio Terracciano; Yang An; Angelina R Sutin; Madhav Thambisetty; Susan M Resnick
Journal:  JAMA Psychiatry       Date:  2017-12-01       Impact factor: 21.596

5.  Personality and Motoric Cognitive Risk Syndrome.

Authors:  Yannick Stephan; Angelina R Sutin; Brice Canada; Antonio Terracciano
Journal:  J Am Geriatr Soc       Date:  2019-12-27       Impact factor: 5.562

6.  Association between personality and cognitive performance in middle-aged and older adults with human immunodeficiency virus (HIV).

Authors:  Pariya L Fazeli; John D Cheatwood; Cierra Hopkins; David E Vance; Maria R Shirey; Andres Azuero; Michael Crowe
Journal:  Appl Neuropsychol Adult       Date:  2021-06-24       Impact factor: 2.050

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.